A genome-wide study of the repressive effects of estrogen receptor beta on estrogen receptor alpha signaling in breast cancer cells

Oncogene

Volumn 27, Issue 7, 2008, Pages 1019-1032

  Williams, C ^a   Edvardsson, K ^a   Lewandowski, S A ^a   Strom A ^a   Gustafsson, J A ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Breast cancer; Estrogen receptor; Gene regulation; Microarray

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

ARTICLE; BREAST CANCER; CANCER CELL; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOMICS; HUMAN; HUMAN CELL; ION TRANSPORT; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEROID METABOLISM; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; XENOBIOTIC METABOLISM;

EID: 38949182981     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210712     Document Type: Article

References (49)

1. Annicotte JS, Chavey C, Servant N, Teyssier J, Bardin A, Licznar A et al. (2005). The nuclear receptor liver receptor homolog-1 is an estrogen receptor target gene. Oncogene 24: 8167-8175.
2. Buterin T, Koch C, Naegeli H. (2006). Convergent transcriptional profiles induced by endogenous estrogen and distinct xenoestrogens in breast cancer cells. Carcinogenesis 27: 1567-1578.
3. Chang EC, Frasor J, Komm B, Katzenellenbogen BS. (2006). Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells. Endocrinology 147: 4831-4842.
4. Chen W-Y, Cheng B-C, Jiang M-J, Hsieh M-Y, Chang M-S. (2006). IL-20 is expressed in atherosclerosis plaques and promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 26: 2090-2095.
5. Esslimani-Sahla M, Kramar A, Simony-Lafontaine J, Warner M, Gustafsson J-A, Rochefort H. (2005). Increased estrogen receptor {beta}cx expression during mammary carcinogenesis. Clin Cancer Res 11: 3170-3174.
6. Frasor J, Danes JM, Funk CC, Katzenellenbogen BS. (2005). Estrogen down-regulation of the corepressor N-CoR: mechanism and implications for estrogen derepression of N-CoR-regulated genes. Proc Natl Acad Sci USA 102: 13153-13157.
7. Frasor J, Danes JM, Komm B, Chang KCN, Lyttle CR, Katzenellenbogen BS. (2003). Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. Endocrinology 144: 4562-4574.
8. Frasor J, Stossi F, Danes JM, Komm B, Lyttle CR, Katzenellenbogen BS. (2004). Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells. Cancer Res 64: 1522-1533.
9. Gougelet A, Mueller SO, Korach KS, Renoir J-M. (2007). Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)[beta]-mediated transcriptional repression of ER[alpha]. J Steroid Biochem Mol Biol 104: 110-122.
10. Gustafsson J. (2006). ERb scientific visions translate to clinical uses. Climacteric 9: 156-160.
11. Hall JM, Korach KS. (2003). Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells. Mol Endocrinol 17: 792-803.
12. Hanstein B, Djahansouzi S, Dall P, Beckmann M, Bender H. (2004). Insights into the molecular biology of the estrogen receptor define novel therapeutic targets for breast cancer. Eur J Endocrinol 150: 243-255.
13. Harris MA, Clark J, Ireland A, Lomax J, Ashburner M, Foulger R et al. (2004). The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 32: D258-D261.
14. Hartman J, Lindberg K, Morani A, Inzunza J, Strom A, Gustafsson J-A. (2006). Estrogen receptor {beta} inhibits angiogenesis and growth of T47D breast cancer xenografts. Cancer Res 66: 11207-11213.
15. Hosack DA, Dennis Jr G, Sherman BT, Lane HC, Lempicki RA. (2003). Identifying biological themes within lists of genes with EASE. Genome Biol 4: R70.
16. Hsieh M-Y, Chen W-Y, Jiang M-J, Cheng B-C, Huang T-Y, Chang M-S. (2006). Interleukin-20 promotes angiogenesis in a direct and indirect manner. Genes Immun 7: 234-242.
17. Hsu Y-H, Li H-H, Hsieh M-Y, Liu M-F, Huang K-Y, Chin L-S et al. (2006). Function of interleukin-20 as a proinflammatory molecule in rheumatoid and experimental arthritis. Arthritis Rheum 54: 2722-2733.
18. Inoue A, Yoshida N, Omoto Y, Oguchi S, Yamori T, Kiyama R et al. (2002). Development of cDNA microarray for expression profiling of estrogen-responsive genes. J Mol Endocrinol 29: 175-192.
19. Kang H, Watkins G, Parr C, Douglas-Jones A, Mansel R, Jiang W. (2005). Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer. Breast Cancer Res 7: R402-R410.
20. Kuiper GGJM, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson J-A. (1996). Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93: 5925-5930.
21. Kurebayashi J, Otsuki T, Kunisue H, Tanaka K, Yamamoto S, Sonoo H. (2000). Expression levels of estrogen receptor-{alpha}, estrogen receptor-{beta}, coactivators, and corepressors in breast cancer. Clin Cancer Res 6: 512-518.
22. Laganiere J, Deblois G, Lefebvre C, Bataille AR, Robert F, Giguere V. (2005). From the cover: location analysis of estrogen receptor {alpha} target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc Natl Acad Sci USA 102: 11651-11656.
23. Lindberg MK, Moverare S, Skrtic S, Gao H, Dahlman-Wright K, Gustafsson J-A et al. (2003). Estrogen receptor (ER)-{beta} reduces ER{alpha}-regulated gene transcription, supporting a 'Ying Yang' relationship between ER{alpha} and ER{beta} in mice. Mol Endocrinol 17: 203-208.
24. Lo Y-L, Yu J-C, Chen S-T, Yang H-C, Fann CSJ, Mau Y-C et al. (2005). Breast cancer risk associated with genotypic polymorphism of the mitosis-regulating gene Aurora-A/ STK15/BTAK. Int J Cancer 115: 276-283.
25. Marshburn PB, Zhang J, Bahrani-Mostafavi Z, Mostafavi BZ, Marroum M-C, Mougeot J-LC et al. (2004). Estrogen receptor-[alpha] messenger RNA variants that lack exon 5 or exon 7 are coexpressed with wild-type form in human endometrium during all phases of the menstrual cycle. Am J Obstet Gynecol 191: 626-633.
26. Matthews J, Wihlen B, Tujague M, Wan J, Strom A, Gustafsson J-A. (2006). Estrogen receptor (ER) {beta} modulates ER{alpha}-mediated transcriptional activation by altering the recruitment of c-Fos and c-Jun to estrogen-responsive promoters. Mol Endocrinol 20: 534-543.
27. McDonnell DP, Norris JD. (2002). Connections and regulation of the human estrogen receptor. Science 296: 1642-1644.
28. Murphy LC, Peng B, Lewis A, Davie JR, Leygue E, Kemp A et al. (2005). Inducible upregulation of oestrogen receptor-{beta}1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells. J Mol Endocrinol 34: 553-566.
29. Nikolova Z, Djonov V, Zuercher G, Andres A, Ziemiecki A. (1998). Cell-type specific and estrogen dependent expression of the receptor tyrosine kinase EphB4 and its ligand ephrin-B2 during mammary gland morphogenesis. J Cell Sci 111: 2741-2751.
30. Nilsson S, Makela S, Treuter E, Tujague M, Thomsen J, Andersson G et al. (2001). Mechanisms of estrogen action. Physiol Rev 81: 1535-1565.
31. Palmieri C, Cheng G, Saji S, Zelada-Hedman M, Warri A, Weihua Z et al. (2002). Estrogen receptor beta in breast cancer. Endocr Relat Cancer 9: 1-13.
32. Park K-J, Krishnan V, O'Malley BW, Yamamoto Y, Gaynor RB. (2005). Formation of an IKK[alpha]-dependent transcription complex is required for estrogen receptor-mediated gene activation. Mol Cell 18: 71-82.
33. Paruthiyil S, Parmar H, Kerekatte V, Cunha GR, Firestone GL, Leitman DC. (2004). Estrogen receptor {beta} inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 64: 423-428.
34. Poola I, Speirs V. (2001). Expression of alternatively spliced estrogen receptor alpha mRNAs is increased in breast cancer tissues. J Steroid Biochem Mol Biol 78: 459-469.
35. Rae JM, Johnson MD, Scheys JO, Cordero KE, Larios JM, Lippman ME. (2005). GREB1 is a critical regulator of hormone dependent breast cancer growth. Breast Cancer Res Treat 92: 141-149.
36. Real PJ, Sierra A, De Juan A, J.C S, Lopez-Vega JM, Fernandez-Luna JL. (2002). Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells. Oncogene 21: 7611-7618.
37. Ricci MS, Toscano DG, Mattingly CJ, Toscano Jr WA. (1999). Estrogen receptor reduces CYP1A1 induction in cultured human endometrial cells. J Biol Chem 274: 3430-3438.
38. Richter K, Wirta V, Dahl L, Bruce S, Lundeberg J, Carlsson L et al. (2006). Global gene expression analyses of hematopoietic stem cell-like cell lines with inducible Lhx2 expression. BMC Genomics 7: [E-pub ahead of print].
39. Roberts M, Wallace J, Jeltsch J-M, Berry M. (1988). The 50 flanking region of the human pS2 gene mediates its transcriptional activation by estrogen in MCF-7 cells. Biochem Biophys Res Commun 151: 306-313.
40. Russo J, Russo IH. (2006). The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol 102: 89-96.
41. Schaefer TM, Wright JA, Pioli PA, Wira CR. (2005). IL-1{beta}-mediated proinflammatory responses are inhibited by estradiol via down-regulation of IL-1 receptor type I in uterine epithelial cells. J Immunol 175: 6509-6516.
42. Smyth G. (2004). Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article 3.
43. Stossi F, Likhite VS, Katzenellenbogen JA, Katzenellenbogen BS. (2006). Estrogen-occupied estrogen receptor represses cyclin G2 gene expression and recruits a repressor complex at the cyclin G2 promoter. J Biol Chem 281: 16272-16278.
44. Strom A, Hartman J, Foster JS, Kietz S, Wimalasena J, Gustafsson J-A. (2004). Estrogen receptor {beta} inhibits 17{beta}-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA 101: 1566-1571.
45. Tokes A-M, Kulka J, Paku S, Szik A, Paska C, Novak P et al. (2005). Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 7: R296-R305.
46. Tomasini R, Seux M, Nowak J, Bontemps C, Carrier A, Dagorn J-C et al. (2005). TP53INP1 is a novel p73 target gene that induces cell cycle arrest and cell death by modulating p73 transcriptional activity. Oncogene 24: 8093-8104.
47. Vlotides G, Eigler T, Melmed S. (2007). Pituitary tumor transforming gene: physiology and implications for tumorigenesis. Endocr Rev 28: 165-186.
48. Wang F, Lee E, Lowes MA, Haider AS, Fuentes-Duculan J, Abello MV et al. (2006). Prominent production of IL-20 by CD68+/CD11c+ myeloid-derived cells in psoriasis: gene regulation and cellular effects. J Invest Dermatol 126: 1590-1599.
49. Wang Y-h, Liu S, Zhang G, Zhou C-q, Zhu H-x, Zhou X-b et al. (2005). Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo. Breast Cancer Res 7: R220-R228.